20-18548589-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006363.6(SEC23B):​c.1744-20T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 1,608,286 control chromosomes in the GnomAD database, including 125,909 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9551 hom., cov: 33)
Exomes 𝑓: 0.40 ( 116358 hom. )

Consequence

SEC23B
NM_006363.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.50

Publications

12 publications found
Variant links:
Genes affected
SEC23B (HGNC:10702): (SEC23 homolog B, COPII coat complex component) The protein encoded by this gene is a member of the SEC23 subfamily of the SEC23/SEC24 family, which is involved in vesicle trafficking. The encoded protein has similarity to yeast Sec23p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. The function of this gene product has been implicated in cargo selection and concentration. Multiple alternatively spliced transcript variants have been identified in this gene. [provided by RefSeq, Feb 2010]
SEC23B Gene-Disease associations (from GenCC):
  • congenital dyserythropoietic anemia type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 7
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital dyserythropoietic anemia
    Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 20-18548589-T-A is Benign according to our data. Variant chr20-18548589-T-A is described in ClinVar as [Benign]. Clinvar id is 95385.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SEC23BNM_006363.6 linkc.1744-20T>A intron_variant Intron 15 of 19 ENST00000650089.1 NP_006354.2 Q15437

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SEC23BENST00000650089.1 linkc.1744-20T>A intron_variant Intron 15 of 19 NM_006363.6 ENSP00000497473.1 Q15437

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
51797
AN:
152010
Hom.:
9552
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.325
Gnomad AMR
AF:
0.314
Gnomad ASJ
AF:
0.212
Gnomad EAS
AF:
0.419
Gnomad SAS
AF:
0.456
Gnomad FIN
AF:
0.442
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.404
Gnomad OTH
AF:
0.302
GnomAD2 exomes
AF:
0.376
AC:
94042
AN:
250294
AF XY:
0.385
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.290
Gnomad ASJ exome
AF:
0.231
Gnomad EAS exome
AF:
0.427
Gnomad FIN exome
AF:
0.434
Gnomad NFE exome
AF:
0.403
Gnomad OTH exome
AF:
0.365
GnomAD4 exome
AF:
0.395
AC:
575785
AN:
1456156
Hom.:
116358
Cov.:
32
AF XY:
0.398
AC XY:
288238
AN XY:
724686
show subpopulations
African (AFR)
AF:
0.208
AC:
6941
AN:
33410
American (AMR)
AF:
0.292
AC:
13028
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
5721
AN:
26100
East Asian (EAS)
AF:
0.362
AC:
14341
AN:
39664
South Asian (SAS)
AF:
0.443
AC:
38154
AN:
86080
European-Finnish (FIN)
AF:
0.438
AC:
23335
AN:
53312
Middle Eastern (MID)
AF:
0.294
AC:
1696
AN:
5760
European-Non Finnish (NFE)
AF:
0.406
AC:
449537
AN:
1106996
Other (OTH)
AF:
0.383
AC:
23032
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
15212
30424
45637
60849
76061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13734
27468
41202
54936
68670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.341
AC:
51807
AN:
152130
Hom.:
9551
Cov.:
33
AF XY:
0.345
AC XY:
25661
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.210
AC:
8707
AN:
41506
American (AMR)
AF:
0.314
AC:
4802
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.212
AC:
737
AN:
3470
East Asian (EAS)
AF:
0.418
AC:
2166
AN:
5178
South Asian (SAS)
AF:
0.458
AC:
2207
AN:
4820
European-Finnish (FIN)
AF:
0.442
AC:
4664
AN:
10562
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.404
AC:
27498
AN:
67994
Other (OTH)
AF:
0.301
AC:
636
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1712
3424
5136
6848
8560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.364
Hom.:
1994
Bravo
AF:
0.321
Asia WGS
AF:
0.403
AC:
1399
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Nov 18, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jul 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital dyserythropoietic anemia, type II;C4225179:Cowden syndrome 7 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cowden syndrome 7 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital dyserythropoietic anemia, type II Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.3
DANN
Benign
0.54
PhyloP100
3.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3736775; hg19: chr20-18529233; COSMIC: COSV52725346; API